Apeloa Pharmaceutical Co. Ltd. – Market Performance and Recent Development Update
Trading Snapshot
- Stock Symbol: 000739.SZ
- Price (02:33 PM Central Europe, Wednesday 21st): CNY 21.15
- Daily Change: 0 % (flat)
- Market Capitalisation: CNY 25.2 bn
- Shares Outstanding: 1.2 bn
- 24‑Hour Volume: CNY 326.5 mn
- Price Relative to 200‑Day SMA: CNY 21.15 versus SMA CNY 20.38
- 52‑Week Range:
- High: CNY 28.5 (08 Oct 2026)
- Low: CNY 14.92 (05 Nov 2025)
Since the close of the previous month, the share price has fallen 12.49 %. The current trading session reflects a neutral market response, with no significant price movement.
Recent Corporate Development
Apeloa Pharmaceutical Co. has released preliminary data from a mid‑stage clinical trial of a weight‑loss candidate. Key points include:
- Population Studied: Female participants.
- Efficacy: The investigational compound produced a statistically significant average weight reduction compared with placebo.
- Additional Benefit: Waist circumference was reduced in the treatment group.
- Trial Size: The study involved a sizeable cohort, providing robust data for early evaluation.
- Future Outlook: The company has not announced a definitive launch date but indicates potential market availability early in 2027.
- Market Implication: Investors view the data as a potential catalyst for the company’s position within the expanding obesity‑treatment segment. No further financial or operational metrics have been disclosed.
Comparative Performance of Related Stocks (Last 24 Hours)
| Ticker | Current Price | Market Cap | P/E Ratio | Notable News |
|---|---|---|---|---|
| 002340.SZ (Gem) | CNY 5.91 | CNY 30 bn | 16.45 | Nickel producers plan to discuss output cuts in response to falling metal prices and regulatory changes. |
| 601696.SS (Boc China) | CNY 10.75 | CNY 30.1 bn | 26.79 | No significant event reported. |
| 301626.SZ (Suzhou Tianmai Thermal Tec) | CNY 267.53 | CNY 30.2 bn | – | No significant event reported. |
| 688295.SS (Zhongfu Shenying Carbon Fi) | CNY 33.4 | CNY 30 bn | 212.32 | STAR Market session saw a rise in borrowing balances, with net buying concentrated in electronics, machinery, and basic chemicals. |
| 300122.SZ (Chongqing Zhifei Biologica) | CNY 12.74 | CNY 29.9 bn | – | No significant event reported. |
All listed stocks remained unchanged in price during the same 24‑hour period, reflecting a broader market pause.
Company Profile
Apeloa Pharmaceutical Co., Ltd. is headquartered in Dongyang, China, and operates within the health‑care sector. The company focuses on the manufacturing and marketing of raw‑material medicines and preparations, covering therapeutic areas such as oncology, antiviral, anti‑infectious, and cardiovascular therapies. Apeloa’s shares are listed on the Shenzhen Stock Exchange, with an IPO conducted on 9 May 1997. Further information can be accessed through the company’s website: www.apeloa.com .
